The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of a prospective multicenter study evaluating a combined circulating tumor DNA (ctDNA) and RNA (ctRNA) liquid biopsy assay in metastatic non-small cell lung cancer (NSCLC).
 
Richa Dawar
No Relationships to Disclose
 
Jennifer Carney
No Relationships to Disclose
 
James Orsini
Honoraria - Exelixis; FirstThought
Consulting or Advisory Role - Exelixis; Janssen Oncology
Speakers' Bureau - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Bristol-Myers Squibb/Pfizer; Exelixis; Seagen
 
Katherine Scilla
Honoraria - OncLive/MJH Life Sciences
Research Funding - AstraZeneca (Inst); Merck (Inst); Teligene (Inst); Turning Point Therapeutics (Inst)
 
Gilberto Lopes
Stock and Other Ownership Interests - Biomab; CDR-Life; Lucence Diagnostics; Morphometrix; Xilis
Honoraria - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Dr. Reddy's Laboratories; Janssen; Merck; Rigel
Consulting or Advisory Role - AstraZeneca; Coherus Biosciences; Dr. Reddy's Laboratories; Mirati Therapeutics; Pfizer; Regeneron
Research Funding - Abbvie (Inst); adaptimmune (Inst); AstraZeneca; AstraZeneca (Inst); Bavarian Nordic (Inst); Blueprint Medicines (Inst); BMS (Inst); E.R. Squibb Sons, LLC; EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); Lucence; Lucence; Merck Sharp & Dohme (Inst); NOVARTIS (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst); Tesaro (Inst); Xilis
Travel, Accommodations, Expenses - AstraZeneca; BeiGene; Boehringer Ingelheim; Celgene; Coherus Biosciences; Dr. Reddy's Laboratories; E.R. Squibb Sons, LLC; Ipsen; Janssen; Merck; Pfizer; Pharmacyclics; Seagen; Seagen
 
Min-Han Tan
No Relationships to Disclose
 
Yew Tan
No Relationships to Disclose
 
Tan Min Chin
No Relationships to Disclose
 
Chee Keong Toh
No Relationships to Disclose
 
Boon Cher Goh
No Relationships to Disclose
 
Jens Samol
No Relationships to Disclose